186 related articles for article (PubMed ID: 32183149)
1. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149
[TBL] [Abstract][Full Text] [Related]
2. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
Slovin SF; Ragupathi G; Musselli C; Fernandez C; Diani M; Verbel D; Danishefsky S; Livingston P; Scher HI
Cancer Immunol Immunother; 2005 Jul; 54(7):694-702. PubMed ID: 15726361
[TBL] [Abstract][Full Text] [Related]
3. Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing.
Trabbic KR; Kleski KA; Shi M; Bourgault JP; Prendergast JM; Dransfield DT; Andreana PR
Cancer Immunol Immunother; 2018 Sep; 67(9):1437-1447. PubMed ID: 30030557
[TBL] [Abstract][Full Text] [Related]
4. Sialyl-Tn Polysaccharide A1 as an Entirely Carbohydrate Immunogen: Synthesis and Immunological Evaluation.
Shi M; Kleski KA; Trabbic KR; Bourgault JP; Andreana PR
J Am Chem Soc; 2016 Nov; 138(43):14264-14272. PubMed ID: 27726393
[TBL] [Abstract][Full Text] [Related]
5. Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.
Trabbic KR; Bourgault JP; Shi M; Clark M; Andreana PR
Org Biomol Chem; 2016 Apr; 14(13):3350-5. PubMed ID: 26958987
[TBL] [Abstract][Full Text] [Related]
6. The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17.
De Silva RA; Appulage DK; Pietraszkiewicz H; Bobbitt KR; Media J; Shaw J; Valeriote FA; Andreana PR
Cancer Immunol Immunother; 2012 Apr; 61(4):581-5. PubMed ID: 22297566
[TBL] [Abstract][Full Text] [Related]
7. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS
ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633
[TBL] [Abstract][Full Text] [Related]
10. Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.
Ravn P; Danielczyk A; Jensen KB; Kristensen P; Christensen PA; Larsen M; Karsten U; Goletz S
J Mol Biol; 2004 Oct; 343(4):985-96. PubMed ID: 15476815
[TBL] [Abstract][Full Text] [Related]
11. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
[TBL] [Abstract][Full Text] [Related]
12. The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2).
da Costa V; van Vliet SJ; Carasi P; Frigerio S; García PA; Croci DO; Festari MF; Costa M; Landeira M; Rodríguez-Zraquia SA; Cagnoni AJ; Cutine AM; Rabinovich GA; Osinaga E; Mariño KV; Freire T
Cancer Lett; 2021 Oct; 518():72-81. PubMed ID: 34144098
[TBL] [Abstract][Full Text] [Related]
13. On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.
Ragupathi G; Coltart DM; Williams LJ; Koide F; Kagan E; Allen J; Harris C; Glunz PW; Livingston PO; Danishefsky SJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13699-704. PubMed ID: 12359877
[TBL] [Abstract][Full Text] [Related]
14. Chemical synthesis and immunological evaluation of entirely carbohydrate conjugate Globo H-PS A1.
Ghosh S; Trabbic KR; Shi M; Nishat S; Eradi P; Kleski KA; Andreana PR
Chem Sci; 2020 Oct; 11(48):13052-13059. PubMed ID: 34123241
[TBL] [Abstract][Full Text] [Related]
15. Chemoenzymatic synthesis and immunological evaluation of sialyl-Thomsen-Friedenreich (sTF) antigen conjugate to CRM197.
Weng W; Ren S; Teng C; Guo J; Guo Q; Zhang W; Zong C; Ding N
Bioorg Med Chem; 2024 Feb; 100():117615. PubMed ID: 38342079
[TBL] [Abstract][Full Text] [Related]
16. Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.
Ulsemer P; Henderson G; Toutounian K; Löffler A; Schmidt J; Karsten U; Blaut M; Goletz S
Cancer Immunol Immunother; 2013 May; 62(5):875-87. PubMed ID: 23381581
[TBL] [Abstract][Full Text] [Related]
17. Novel immunogenicity of Thomsen-Friedenreich disaccharide obtained by a molecular rotation on its carrier linkage.
Irazoqui FJ; Lopez PH; Vides MA; Nores GA
Glycobiology; 2000 Aug; 10(8):781-7. PubMed ID: 10929004
[TBL] [Abstract][Full Text] [Related]
18. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
[TBL] [Abstract][Full Text] [Related]
19. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
Kurtenkov O; Izotova J; Klaamas K; Sergeyev B
Biomed Res Int; 2014; 2014():830847. PubMed ID: 25276822
[TBL] [Abstract][Full Text] [Related]
20. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients.
Kurtenkov O; Bubina M; Klaamas K
Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
